Alterations in host-cell biology due to toxoplasma gondii

Toxoplasma Gondii

Volumn , Issue , 2007, Pages 317-340

  Dunn, J D ^a   Butcher, B ^b   Denkers, E ^a   Boothroyd, J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 57549112616     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369542-0/50014-3     Document Type: Chapter

References (146)

1. Alexaki V.I., Charalampopoulos I., Kampa M., et al. Activation of membrane estrogen receptors induces pro-survival kinases. J. Steroid Biochem. Mol. Biol. 2006, 98:97-110.
2. Alexander D.L., Mital J., Ward G.E., Bradley P., Boothroyd J.C. Identification of the moving junction complex of Toxoplasma gondii: a collabora- tion between distinct secretory organelles. PLoS Pathog. 2005, 1:e17.
3. Aliberti J., Reis Sousa C., Schito M., et al. CCR5 provides a signal for microbial induced production of IL-12 by CD8a+ dendritic cells. Nature Immunol. 2000, 1:83-87.
4. Aliberti J., Valenzuela J.G., Carruthers V.B., et al. Molecular mimicry of a CCR5 binding-domain in the microbial activation of dendritic cells. Nature Immunol. 2003, 4:485-490.
5. Al Safarjalani O.N., Naguib F.N., El Kouni M.H. Uptake of nitrobenzylthioinosine and purine beta-L-nucleosides by intracellular Toxoplasma gondii. Antimicrob. Agents Chemother. 2003, 47:3247-3451.
6. Andrews S.C., Robinson A.K., Rodriguez-Quinones F. Bacterial iron homeostasis. FEMS Microbiol. Rev. 2003, 27:215-237.
7. Asai T., O'Sullivan W.J., Kobayashi M., Gero A.M., Yokogawa M., Tatibana M. Enzymes of the de novo pyrimidine biosynthetic pathway in Toxoplasma gondii. Mol. Biochem. Parasitol. 1983, 7:89-100.
8. Azzouz N., Rauscher B., Gerold P., Cesbron-Delauw M.F., Dubremetz J.F., Schwarz R.T. Evidence for de novo sphingolipid biosynthesis in Toxoplasma gondii. Intl J. Parasitol. 2002, 32:677-684.
9. Beckers C.J., Dubremetz J.F., Mercereau-Puijalon O., Joiner K.A. The Toxoplasma gondii rhop-try protein ROP 2 is inserted into the parasitophorous vacuole membrane, surrounding the intracellular parasite, and is exposed host cell cytoplasm. J. Cell Biol. 1994, 127:947-961.
10. Beckers C.J., Wakefield T., Joiner K.A. The expression of Toxoplasma proteins in Neospora caninum and the identification of a gene encoding a novel rhoptry protein. Mol. Biochem. Parasitol. 1997, 89:209-223.
11. Bermudes D., Peck K.R., Afifi M.A., Beckers C.J., Joiner K.A. Tandemly repeated genes encode nucleoside triphosphate hydrolase isoforms secreted into the parasitophorous vacuole of Toxoplasma gondii. J. Biol. Chem. 1994, 269:29 252-29 260.
12. Black M.W., Arrizabalaga G., Boothroyd J.C. Ionophore-resistant mutants of Toxoplasma gondii reveal host cell permeabilization as an early event in egress. Mol. Cell Biol. 2000, 20:9399-9408.
13. Blader I.J., Manger I.D., Boothroyd J.C. Microarray analysis reveals previously unknown changes in Toxoplasma gondii-infected human cells. J. Biol. Chem. 2001, 276:24 223-24 231.
14. Bliss S.K., Zhang Y., Denkers E.Y. Murine neutrophil stimulation by Toxoplasma gondii antigen drives high level production of IFN-gamma-independent IL-12. J. Immunol. 1999, 163:2081-2088.
15. Blume-Jensen P., Janknecht R., Hunter T. The kit receptor promotes cell survival via activation of PI3-kinase and subsequent Akt-mediated phos-phorylation of Bad on Ser136. Curr. Biol. 1998, 8:779-782.
16. Bradley P.J., Ward C., Cheng D.L., et al. Proteomic analysis of rhoptry organelles reveals many novel constituents for host-parasite interactions in Toxoplasmagondii. J. Biol. Chem. 2005, 280:34 245-34 258.
17. Brunet A., Bonni A., Zigmond M.J., et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999, 96:857-868.
18. Butcher B.A., Denkers E.Y. Mechanism of entry determines ability of Toxoplasma gondii to inhibit macrophage proinflammatory cytokine production. Infect. Immun. 2002, 70:5216-5224.
19. Butcher B.A., Kim L., Johnson P.F., Denkers E.Y. Toxoplasma gondii tachyzoites inhibit proin- flammatory cytokine induction in infected macrophages by preventing nuclear translocation of the transcription fa. J. Immunol. 2001, 167:2193-2201.
20. Butcher B.A., Kim L., Panopoulos A., Watowich S.S., Murray P.J., Denkers E.Y. Cutting edge, IL- 10-independent STAT3 activation by Toxoplasma gondii mediates suppression of IL-12 and TNF-α in host macrophages. J. Immunol. 2005, 174:3148-3152.
21. Cardone M.H., Roy N., Stennicke H.R., et al. Regulation of cell death protease caspase-9 by phos-phorylation. Science 1998, 282:1318-1321.
22. Carey K.L., Jongco A.M., Kim K., Ward G.E. The Toxoplasma gondii rhoptry protein ROP4 is secreted into the parasitophorous vacuole and becomes phosphorylated in infected cells. Eukaryot. Cell 2004, 3:1320-1330.
23. Chandel N.S., Maltepe E., Goldwasser E., Mathieu C.E., Simon M.C., Schumacker P.T. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc. Natl Acad. Sci. USA 1998, 95:11715-11720.
24. Chandel N.S., McClintock D.S., Feliciano C.E., et al. Reactive oxygen species generated at mito- chondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia, a mechanism of O2 sensing. J. Biol. Chem. 2000, 275:25 130-25 138.
25. Charron A.J., Sibley L.D. Host cells, mobiliz- able lipid resources for the intracellular parasite Toxoplasmagondii. J. Cell Sci. 2002, 115:3049-3059. (Pt 15).
26. Charron A.J., Sibley L.D. Molecular partition- ing during host cell penetration by Toxoplasma gondii. Traffic 2004, 5:855-867.
27. Chaudhary K., Darling J.A., Fohl L.M., et al. Purine salvage pathways in the apicomplexan parasite Toxoplasmagondii. J. Biol. Chem. 2004, 279:31 221-31 227.
28. Chiang C.W., Carter N., Sullivan W.J., et al. The adenosine transporter of Toxoplasma gondii. Identification by insertional mutagenesis, cloning, and recombinant expression. J. Biol. Chem. 1999, 274:35 255-35 261.
29. Coppens I., Joiner K.A. Host but not parasite cholesterol controls Toxoplasma cell entry by modulat- ing organelle discharge. Mol. Biol. Cell 2003, 14:3804-3820.
30. Coppens I., Dunn J.D., Romano J.D., et al. Toxoplasma gondii sequesters lysosomes from mammalian hosts in the vacuolar space. Cell 2006, 125:261-274.
31. Coppens I., Sinai A.P., Joiner K.A. Toxoplasma gondii exploits host low-density lipopro- tein receptor-mediated endocytosis for cholesterol acquisition. J. Cell Biol. 2000, 149:167-180.
32. Courret N., Darche S., Sonigo P., Milon G., BuzoniGatel D., Tardieux I. CD11c- and CD11b- expressing mouse leukocytes transport single Toxoplasma gondii tachyzoites to the brain. Blood 2006, 107:309-316.
33. Dai W., Pan H., Kwok O., Dubey J.P. Human indoleamine 2,3-dioxygenase inhibits Toxoplasma gondii growth in fibroblast cells. J. Interferon Res. 1994, 14:313-317.
34. De Koning H.P., Al-Salabi M.I., Cohen A.M., Coombs G.H., Wastling J.M. Identification and characterisation of high affinity nucleoside and nucleobase transporters in Toxoplasma gondii. Intl J. Parasitol. 2003, 33:821-831.
35. De Melo E.J., De Carvalho T.U., De Souza W. Penetration of Toxoplasma gondii into host cells induces changes in the distribution of the mitochon-dria and the endoplasmic reticulum. Cell Struct. Funct. 1992, 17:311-317.
36. Del Peso L., Gonzalez-Garcia M., Page C., Herrera R., Nunez G. Interleukin-3-induced phos-phorylation of BAD through the protein kinase Akt. Science 1997, 278:687-689.
37. Del Rio L., Butcher B.A., Bennouna S., Hieny S., Sher A., Denkers E.Y. Toxoplasma gondii triggers MyD88-dependent and CCL2 (MCP-1) responses using distinct parasite molecules and host receptors. J. Immunol. 2004, 172:6954-6960.
38. Dimier I.H., Bout D.T. Interferon-gamma-activated primary enterocytes inhibit Toxoplasma gondii replication, a role for intracellular iron. Immunology 1998, 94:488-495.
39. Dobrowolski J.M., Sibley L.D. Toxoplasma invasion of mammalian cells is powered by the actin cytoskeleton of the parasite. Cell 1996, 84:933-939.
40. Dobrovolskaia M.A., Vogel S.N. Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect. 2002, 4:903-914.
41. Dobrowolski J.M., Carruthers V.B., Sibley L.D. Participation of myosin in glidingmotility and host cell invasion by Toxoplasma gondii. Mol. Microbiol. 1997, 26:163-173.
42. Dong C., Davis R.J., Flavell R.A. MAP kinases in the immune response. Annu. Rev. Immunol. 2002, 20:55-72.
43. Dubremetz J.F., Achbarou A., Bermudes D., Joiner K.A. Kinetics and pattern of organelle exocy-tosis during Toxoplasma gondii / host-cell interac-tion. Parasitol. Res. 1993, 79:402-408.
44. Dziadek B., Dzitko K., Dlugonska H. Toxoplasma gondii binds human lactoferrin but not transferrin. Exp. Parasitol. 2005, 110:165-167.
45. Ferguson D.J.P., Huskinson-Mark J., Araujo F.G., Remington J.S. A morphological study of chronic cerebral toxoplasmosis in mice, comparison of four different strains of Toxoplasma gondii. Parasitol. Res. 1994, 80:493-501.
46. Fouts A.E., Boothroyd J.C. Infection with Toxoplasma bradyzoites has a diminished impact on host cell-transcript levels relative to tachyzoite infection. Infect. Immunol. 2006, 6 Nov (e-pub).
47. Fox B.A., Bzik D.J. De novo pyrimidine biosynthesis is required for virulence of Toxoplasma gondii. Nature 2002, 415:926-929.
48. Fox B.A., Gigley J.P., Bzik D.J. Toxoplasma gondii lacks the enzymes required for de novo argi- nine biosynthesis and arginine starvation triggers cyst formation. Intl J. Parasitol. 2004, 34:323-331.
49. Fulton J.D., Spooner D.F. Metabolic studies on Toxoplasma gondii. Exp. Parasitol 1960, 9:293-301.
50. Gail M., Gross U., Bohne W. Transcriptional profile of Toxoplasma gondii-infected human fibro- blasts as revealed by gene-array hybridization. Mol. Genet. Genomics 2001, 265:905-912.
51. Gail M., Gross U., Bohne W. Transferrin receptor induction in Toxoplasma gondii-infected HFF is associated with increased iron-responsive protein 1 activity and is mediated by secreted f. Parasitol. Res. 2004, 94:233-239.
52. Gavrilescu L.C., Denkers E.Y. IFN-γ overpro- duction and high level apoptosis are associated with high but not low virulence Toxoplasma gondii infection. J. Immunol. 2001, 167:902-909.
53. Gavrilescu L.C., Denkers E.Y. Interleukin-12 p40- and Fas ligand-dependent apoptotic pathways involving STAT-1 phosphorylation are triggered during infection with a virulent strain of Toxo. Infect. Immun. 2003, 71:2577-2583.
54. Ge B., Gram H., Di Padova B., et al. MAPKK-inde- pendent activation of p38alpha mediated by TAB1- dependent autophosphorylation of p38alpha. Science 2002, 295:1291-1294.
55. Ge B., Xiong X., Jing J.L., et al. TAB1beta (trans- forming growth factor-beta-activated protein kinase 1-binding protein 1beta), a novel splicing variant of TAB1 that interacts with p38alpha b. J. Biol. Chem. 2003, 278:2286-2293.
56. Gilbert L.A., Ravindran S., Turetzky J.M., Boothroyd J.C., Bradley P. Toxoplasma gondii targets a protein phosphatase 2C to the nucleus of infected host cells. Eukaryot. Cell 2006, 3 Nov (e-pub).
57. Goebel S., Luder C.G., Gross U. Invasion by Toxoplasma gondii protects human-derived HL-60 cells from actinomycin D-induced apoptosis. Med. Microbiol. Immunol. (Berl.) 1999, 187:221-226.
58. Goebel S., Gross U., Luder C.G.K. Inhibition of host cell apoptosis by Toxoplasma gondii is accom- panied by reduced activation of the caspase cascade and alterations of poly (ADP-ribose) polymerase expression. J. Cell Sci. 2001, 114:3495-3505.
59. Green D.R., Reed J.C. Mitochondria and apoptosis. Science 1998, 281:1309-1312.
60. Grimwood J., Smith J.E. Toxoplasma gondii, the role of parasite surface and secreted proteins in host cell invasion. Intl J. Parasitol. 1996, 26:169-173.
61. Gubbels M.J., Striepen B., Shastri N., Turkoz M., Robey E.A. Class I major histocompatibility complex presentation of antigens that escape from the parasitophorous vacuole of Toxoplasma gondii. Infect. Immun. 2005, 73:703-711.
62. Hakansson S., Charron A.J., Sibley L.D. Toxoplasma evacuoles, a two-step process of secre- tion and fusion forms the parasitophorous vacuole. EMBOJ. 2001, 20:3132-3144.
63. Halonen S.K., Weidner E. Overcoating of Toxoplasma parasitophorous vacuoles with host cell vimentin type intermediate filaments. J. Eukaryot. Microbiol. 1994, 41:65-71.
64. Hentze M.W., Rouault T.A., Harford J.B., Klausner R.D. Oxidation-reduction and the molecular mechanism of a regulatory RNA-protein interaction. Science 1989, 244:357-359.
65. Herion P., Hernandez-Pando R., Dubremetz J.F., Saavedra R. Subcellular localization of the 54-kDa antigen of Toxoplasma gondii. J. Parasitol. 1993, 79:216-222.
66. High K.P., Joiner K.A., Handschumacher R.E. Isolation, cDNA sequences, and biochemical charac-terization of the major cyclosporin-binding proteins of Toxoplasma gondii. J. Biol. Chem. 1994, 269:9105-9112.
67. Hiller N.L., Bhattacharjee S., Van Ooij C., et al. A host-targeting signal in virulence proteins reveals a secretome in malarial infection. Science 2004, 306:1934-1937.
68. Howe D.K., Sibley L.D. Toxoplasma gondii comprises three clonal lineages, correlation of para-site genotype with human diseases. J. Infect. Dis. 1995, 172:1561-1566.
69. Iltzsch M.H. Pyrimidine salvage pathways in Toxoplasma gondii. J. Eukaryot. Microbiol. 1993, 40:24-28.
70. Joet T., Holterman L., Stedman X.X., et al. Comparative characterization of hexose transporters of Plasmodium knowlesi, Plasmodium yoelii and Toxoplasma gondii highlights functional differences within t apicomplexan family. Biochem. J. 2002, 368:923-929. (Pt 3).
71. Kadota K., Ishino T., Matsuyama T., Chinzei Y., Yuda M. Essential role of membrane-attack protein in malarial transmission to mosquito host. Proc. Natl Acad. Sci. USA 2004, 101:16 310-16 315.
72. Kaiser K., Camargo N., Coppens I., Morrisey J.M., Vaidya A.B., Kappe S.H. A member of a conserved Plasmodium protein family with membrane-attack complex/perforin (MACPF)-like domains localizes to the micronemes of sporozoites. Mol. Biochem. Parasitol. 2004, 133:15-26.
73. Karin M., Ben-Neriah Y. Phosphorylation meets ubiquitination, the control of NF-kB activity. Annu. Rev. Immunol. 2000, 18:621-663.
74. Karin M., Lin A. NF-kappaB at the crossroads of life and death. Nature Immunol. 2002, 3:221-227.
75. Khan I.A., Schwartzman J.D., Matsuura X, Kasper L.H. A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice. Proc. Natl. Acad. Sci. USA 1997, 94:13 955-13 960.
76. Kim L., Denkers E.Y. Toxoplasma gondii trig- gers Gi-dependent phosphatidylinositol 3-kinase signaling required for inhibition of host cell apoptosis. J. Cell Sci. 2006, 119:2119-2126. (Pt 10).
77. Kim L., Butcher B.A., Denkers E.Y. Toxoplasma gondii interferes with lipopolysaccharide- induced mitogen-activated protein kinase activation by mechanisms distinct from endotoxin tolerance. J. Immunol. 2004, 172:3003-3010.
78. Kim L., Del Rio L., Butcher B.A., et al. p38 MAPK autophosphorylation drives macrophage IL-12 production during intracellular infection. J. Immunol. 2005, 174:4178-4184.
79. Koeller D.M., Casey J.L., Hentze M.W., et al. A cytosolic protein binds to structural elements within the iron regulatory region of the transferrin receptor mRNA. Proc. Natl Acad. Sci. USA 1989, 86:3574-3578.
80. Krug E.C., Marr J.J., Berens R.L. Purine metabolism in Toxoplasma gondii. J. Biol. Chem. 1989, 264:10 601-10 607.
81. Labruyere E., Lingnau M., Mercier C., Sibley L.D. Differential membrane targeting of the secre-tory proteins GRA4 and GRA6 within the para-sitophorous vacuole formed by Toxoplasma gondii. Mol. Biochem. Parasitol. 1999, 102:311-324.
82. Lee C.W., Bennouna S., Denkers E.Y. Screening for Toxoplasma gondii regulated transcrip- tional responses in LPS-activated macrophages. Infect. Immun. 2006, 74:1916-1923.
83. Liesenfeld O., Kosek J., Remington J.S., Suzuki Y. Association of CD4+ T cell-dependent, IFN-γ-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasm. J. Exp. Med. 1996, 184:597-607.
84. Liesenfeld O., Kosek J.C., Suzuki Y. Gamma interferon induces Fas-dependent apoptosis of Peyer's patch T cells in mice following peroral infec-tion with Toxoplasma gondii. Infect. Immun. 1997, 65:4682-4689.
85. Liesenfeld O., Kang H., Park D. TNF-α, nitric oxide and IFN-γare all critical for development of necrosis in the small intestine and early mortality in genetically susceptible mice infec perorally with Toxoplasma gondii. Parasite Immunol. 1999, 21:365-376.
86. Lingelbach K., Joiner K.A. The para-sitophorous vacuole membrane surrounding Plasmodium and Toxoplasma, an unusual compart-ment in infected cells. J. Cell Sci. 1998, 111:1467-1475. (Pt 11).
87. Machado J.J., Fernandez P.C., Baumann I., Dobbelaere D.A.E. Characterization of NF-B complexes in Theileria parva-transformed T cells. Microbes Infect. 2000, 2:1311-1320.
88. Magno R.C., Straker L.C., De Souza W., Attias M. Interrelations between the parasitophorous vacuole of Toxoplasma gondii and host cell organelles. Microsc. Microanal. 2005, 11:166-174.
89. Magno R.C., Lemgruber L., Vommaro R.C., De Souza W., Attias M. Intravacuolar network may act as a mechanical support for Toxoplasma gondii inside the parasitophorous vacuole. Microsc. Res. Tech. 2005, 67:45-52.
90. Marti M., Good R.T., Rug M., Knuepfer E., Cowman A.F. Targeting malaria virulence and remodeling proteins to the host erythrocyte. Science 2004, 306:1930-1933.
91. Mercier C., Dubremetz J.F., Rauscher B., Lecordier L., Sibley L.D., Cesbron-Delauw M.F. Biogenesis of nanotubular network in Toxoplasma parasitophorous vacuole induced by parasite proteins. Mol. Biol. Cell 2002, 13:2397-2409.
92. Mercier C., Adjogble K.D., Rauscher B., Lecordier L., Sibley L.D., Cesbron-Delauw M.F. Dense granules, are they key organelles to help understand the parasitophorous vacuole of all apicomplexa para- sites?. Intl J. Parasitol. 2005, 35:829-849.
93. Molestina R.E., Sinai A.P. Detection of a novel parasite kinase activity at the Toxoplasma gondii parasitophorous vacuole membrane capable of phosphorylating host IkappaBalpha. Cell Microbiol. 2005, 7:351-362.
94. Molestina R.E., Payne T.M., Coppens I., Sinai A.P. Activation of NF-kappaB by Toxoplasma gondii correlates with increased expression of anti- apoptotic genes and localization of phosphorylated IkappaB to the parasitophorous vacuole membrane. J. Cell Sci. 2003, 116:4359-4371. (Pt 21).
95. Mordue D.G., Sibley L.D. Intracellular fate of vacuoles containing Toxoplasma gondii is deter- mined at the time of formation and depends on the mechanism of entry. J. Immunol 1997, 159:4452-4459.
96. Mordue D.G., Hakansson S., Niesman I., Sibley L.D. Toxoplasma gondii resides in a vacuole that avoids fusion with host cell endocytic and exocytic vesicular trafficking pathways. Exp. Parasitol. 1999, 92:87-99.
97. Mordue D.G., Desai N., Dustin M., Sibley L.D. Invasion by Toxoplasma gondii establishes a moving junction that selectively excludes host cell plasma membrane proteins on the basis of their membrane an. J. Exp Med. 1999, 190:1783-1792.
98. Mordue D.G., Monroy F., La Regina M., Dinarello C.A., Sibley L.D. Acute toxoplasmosis leads to lethal overproduction of Th1 cytokines. J. Immunol. 2001, 167:4574-4584.
99. Morris M.T., Carruthers V.B. Identification and partial characterization of a second Kazal inhibitor in Toxoplasma gondii. Mol. Biochem. Parasitol. 2003, 128:119-122.
100. Morris M.T., Coppin A., Tomavo S., Carruthers V.B. Functional analysis of Toxoplasma gondii protease inhibitor 1. J. Biol. Chem. 2002, 277:45 259-45 266.
101. Mun H.-S., Aosai F., Norose M., et al. TLR2 as an essential molecule for protective immunity against Toxoplasma gondii infection. Intl Parasitol. 2003, 15:1081-1087.
102. Nakaar V., Ngo H.M., Aaronson E.P., Coppens I., Stedman T.T., Joiner K.A. Pleiotropic effect due to targeted depletion of secretory rhoptry protein ROP2 in Toxoplasma gondii. J. Cell Sci. 2003, 116:2311-2320. (Pt 11).
103. Nash P.B., Purner M.B., Leon R.P., Clarke P., Duke R.C., Curiel T.J. Toxoplasma gondii-infected cells are resistant to multiple inducers of apoptosis. J. Immunol. 1998, 160:1824-1830.
104. Neudeck A., Stachelhaus S., Nischik N., Striepen B., Reichmann G., Fischer H.G. Expression variance, biochemical and immunological properties of Toxoplasma gondii dense granule protein GRA7. Microbes Infect. 2002, 4:581-590.
105. Ngo H.M., Ngo E.O., Bzik D.J., Joiner K.A. Toxoplasma gondii, are host cell adenosine nucleotides a direct source for purine salvage?. Exp. Parasitol. 2000, 95:148-153.
106. Nicholson D.W. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ. 1999, 6:1028-1042.
107. O'Sullivan W.J., Johnson A.M., Finney K.G., et al. Pyrimidine and purine enzymes in Toxoplasma gondii. Aust. J. Exp. Biol. Med. Sci. 1981, 59:763-767. (Pt 6).
108. Pantopoulos K., Hentze M.W. Rapid responses to oxidative stress mediated by iron regulatory protein. EMBOJ. 1995, 14:2917-2924.
109. Pantopoulos K., Hentze M.W. Activation of iron regulatory protein-1 by oxidative stress in vitro. Proc. Natl Acad. Sci. USA 1998, 95:10 559-10 563.
110. Pantopoulos K., Mueller S., Atzberger A., Ansorge W., Stremmel W., Hentze M.W. Differences in the regulation of iron regulatory protein-1 (IRP-1) by extra-and intracellular oxidative stress. J. Biol. Chem. 1997, 272:9802-9808.
111. Payne T.M., Molestina R.E., Sinai A.P. Inhibition of caspase activation and a requirement for NF-kappaB function in the Toxoplasma gondii- mediated blockade of host apoptosis. J. Cell Sci. 2003, 116:4345-4358. (Pt 21).
112. Pfefferkorn E.R. Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc. Natl Acad. Sci. USA 1984, 81:908-912.
113. Pfefferkorn E.R., Eckel M., Rebhun S. Interferon-gamma suppresses the growth of Toxoplasma gondii in human fibroblasts through starvation for tryptophan. Mol. Biochem. Parasitol. 1986, 20:215-224.
114. Pingret L., Millot J.M., Sharonov S., Bonhomme A., Manfait M., Pinon J.M. Relationship between intracellular free calcium concentrations and the intracellular development of Toxoplasma gondii. J. Histochem. Cytochem. 1996, 44:1123-1129.
115. Robben P.M., Mordue D.G., Truscott S.M., Takeda K., Akira S., Sibley L.D. Production of IL-12 by macrophages infected with Toxoplasma gondii depends on the parasite genotype. J. Immunol. 2004, 172:3686-3694.
116. Robibaro B., Hoppe H.C., Yang M., et al. Endocytosis in different lifestyles of protozoan para- sitism, role in nutrient uptake with special reference to Toxoplasma gondii. Intl J. Parasitol. 2001, 31:1343-1353.
117. Robibaro B., Stedman T.T., Coppens I., et al. Toxoplasma gondii Rab5 enhances cholesterol acquisition from host cells. Cell Microbiol. 2002, 4:139-152.
118. Saeij J.P., Boyle J.P., Boothroyd J.C. Differences among the three major strains of Toxoplasma gondii and their specific interactions with the infected host. Trends Parasitol. 2005, 21:476-481.
119. Schaible U.E., Kaufmann S.H. Iron and microbial infection. Nature Rev. Microbiol. 2004, 2:946-953.
120. Schwab J.C., Beckers C.J., Joiner K.A. The parasitophorous vacuole membrane surrounding intracellular Toxoplasma gondii functions as a molecular sieve. Proc. Natl Acad. Sci. USA 1994, 91:509-513.
121. Schwab J.C., Afifi Afifi M., Pizzorno G., Handschumacher R.E., Joiner K.A. Toxoplasma gondii tachyzoites possess an unusual plasma membrane adenosine transporter. Mol. Biochem. Parasitol. 1995, 70:59-69.
122. Schwartzman J.D., Pfefferkorn E.R. Pyrimidine synthesis by intracellular Toxoplasma gondii. J. Parasitol. 1981, 67:150-158.
123. Schwartzman J.D., Pfefferkorn E.R. Toxoplasma gondii, purine synthesis and salvage in mutant host cells and parasites. Exp. Parasitol. 1982, 53:77-86.
124. Seabra S.H., DaMatta R.A., De Mello F.G., De Souza W. Endogenous polyamine levels in macrophages is sufficient to support growth of Toxoplasma gondii. J. Parasitol. 2004, 90:455-460.
125. Sehgal A., Bettiol S., Pypaert M., et al. Peculiarities of host cholesterol transport to the unique intracellular vacuole containing toxoplasma. Traffic 2005, 6:1125-1141.
126. Shapira S.S., Speirs K., Gerstein A., Caamano J., Hunter C.A. Suppression of NF-κB activation by infection with Toxoplasma gondii. J. Infect. Dis. 2002, 185:S66-s72.
127. Shapira S., Harb O., Margarit J., et al. Initiation and termination of NF-κB signaling by the intracellu- lar protozoan parasite Toxoplasma gondii. J. Cell Sci. 2005, 118:3501-3508.
128. Shuai K., Liu B. Regulation of JAK-STAT signalling in the immune system. Nature Rev. Immunol. 2003, 3:900-911.
129. Sibley L.D., Krahenbuhl J.L., Adams G.M., Weidner E. Toxoplasma modifies macrophage phago-somes by secretion of a vesicular network rich in surface proteins. J. Cell Biol. 1986, 103:867-874.
130. Sibley L.D., Niesman I.R., Parmley S.F., CesbronDelauw M.F. Regulated secretion of multi- lamellar vesicles leads to formation of a tubulo-vesicular network in host-cell vacuoles occu- pied by Toxoplasma gondii. J. Cell Sci. 1995, 108:1669-1677. (Pt 4).
131. Silverman J.A., Qi H., Riehl A., Beckers C., Nakaar V., Joiner K.A. Induced activation of the Toxoplasma gondii nucleoside triphosphate hydro-lase leads to depletion of host cell ATP levels and rapid exit of intracellular from infected cells. J. Biol. Chem. 1998, 273:12 352-12 359.
132. Sinai A.P., Joiner K.A. Safe haven, the cell biology of nonfusogenic pathogen vacuoles. Annu. Rev. Microbiol. 1997, 51:415-462.
133. Sinai A.P., Joiner K.A. The Toxoplasma gondii protein ROP2 mediates host organelle association with the parasitophorous vacuole membrane. J. Cell Biol. 2001, 154:95-108.
134. Sinai A.P., Webster P., Joiner K.A. Association of host cell endoplasmic reticulum and mitochondria with the Toxoplasma gondii parasitophorous vacuole membrane, a high affinity interaction. J. Cell Sci. 1997, 110:2117-2128. (Pt 17).
135. Spear W., Chan D., Coppens I., Johnson R.S., Giaccia A., Blader I.J. The host cell transcription factor hypoxia-inducible factor 1 is required for Toxoplasma gondii growth and survival at physiolog- ical oxygen levels. Cell Microbiol. 2006, 8:339-352.
136. 2+ flux causes egress of parasites from the para-sitophorous vacuole. Exp. Parasitol. 1997, 87:88-97.
137. Suss-Toby E., Zimmerberg J., Ward G.E. Toxoplasma invasion, the parasitophorous vacuole is formed from host cell plasma membrane and pinches off via a fission pore. Proc. Natl Acad. Sci. USA 1996, 93:8413-8418.
138. Suzuki Y., Conley F.K., Remington J.S. Differences in virulence and development of encephalitis during chronic infection vary with strain of Toxoplasma gondii. J. Infect. Dis. 1989, 790:790-794.
139. Takeda K., Akira S. Toll-like receptors in innate immunity. Intl Immunol. 2005, 17:1-14.
140. Takeda K., Clausen B.E., Kaisho T., et al. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of stat3 in macrophages and neutrophils. Immunity 1999, 10:39-49.
141. Tanaka T., Abe Y., Kim W.S., et al. The detection of bovine lactoferrin binding protein on Toxoplasma gondii. J. Vet. Med. Sci. 2003, 65:1377-1380.
142. Tilley M., Fichera M.E., Jerome M.E., Roos D.S., White M.W. Toxoplasma gondii sporozoites form a transient parasitophorous vacuole that is impermeable and contains only a subset of dense-granule proteins. Infect. Immun. 1997, 65:4598-4605.
143. Valere A., Garnotel R., Villena I., Guenounou M., Pinon J.M., Aubert D. Activation of the cellular mitogen-activated protein kinase pathways ERK.p38 and JNK during Toxoplasma gondii inva- sion. Parasite 2003, 10:59-64.
144. Wallach D., Varfolomeev E.E., Malinin N.L., Goltsev Y.V., Koyalenko A.V., Boldin M.P. Tumor necrosis factor receptor and Fas signaling mecha-nisms. Annu. Rev. Immunol. 1999, 17:331-367.
145. Yarovinsky F., Zhang D., Anderson J.F., et al. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 2005, 308:1626-1629.
146. Zhou X.W., Kafsack B.F., Cole R.N., Beckett P., Shen R.F., Carruthers V.B. The opportunistic pathogen Toxoplasma gondii deploys a diverse legion of invasion and survival proteins. J. Biol. Chem. 2005, 280:34 233-34 244.